Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group..

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236.

2.

Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.

Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Collaborative Group..

Stroke. 2015 Mar;46(3):746-56. doi: 10.1161/STROKEAHA.114.006573. Erratum in: Stroke. 2015 Mar;46(3):e73.

3.

Continuous versus intermittent physiological monitoring for acute stroke.

Ciccone A, Celani MG, Chiaramonte R, Rossi C, Righetti E.

Cochrane Database Syst Rev. 2013 May 31;(5):CD008444. doi: 10.1002/14651858.CD008444.pub2. Review.

PMID:
23728675
4.

Piracetam for acute ischaemic stroke.

Ricci S, Celani MG, Cantisani TA, Righetti E.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000419. doi: 10.1002/14651858.CD000419.pub3. Review.

PMID:
22972044
5.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group., Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

6.

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; VITATOPS trial study group..

Lancet Neurol. 2012 Jun;11(6):512-20. doi: 10.1016/S1474-4422(12)70091-1.

7.

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group..

Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.

8.

The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials.

Dennis M, Mordi N, Graham C, Sandercock P; CLOTS trials collaboration..

J Thromb Haemost. 2011 Nov;9(11):2193-200. doi: 10.1111/j.1538-7836.2011.04486.x.

10.

Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptoms.

Brazzelli M, Sandercock PA, Chappell FM, Celani MG, Righetti E, Arestis N, Wardlaw JM, Deeks JJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007424. doi: 10.1002/14651858.CD007424.pub2. Review.

PMID:
19821415
11.

Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial.

CLOTS Trials Collaboration., Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G.

Lancet. 2009 Jun 6;373(9679):1958-65. doi: 10.1016/S0140-6736(09)60941-7.

12.

EPITHET--where next?

Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G; IST-3 Collaborative Group..

Lancet Neurol. 2008 Jul;7(7):570-1; author reply 571-3. doi: 10.1016/S1474-4422(08)70123-6. No abstract available.

PMID:
18565447
13.

Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P; IST-3 Collaborative Group..

Trials. 2008 Jun 17;9:37. doi: 10.1186/1745-6215-9-37.

14.

Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3).

SCOPE (Stroke Complications and Outcomes Prediction Engine) Collaborations.; IST., Lewis SC, Sandercock PA, Dennis MS.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):397-400.

PMID:
17766429
15.

Prevention of venous thromboembolism after acute ischaemic stroke.

Ricci S, Celani MG, Righetti E, Dennis M, Sandercock P.

Lancet. 2007 Sep 1;370(9589):735-6; author reply 736-7. No abstract available.

PMID:
17765511
16.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Cusi C, Cantisani TA, Celani MG, Incorvaia B, Righetti E, Candelise L; Cochrane Neurological Network..

Neuroepidemiology. 2007;28(2):116-7. No abstract available.

PMID:
17409773
17.

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.

ESPRIT Study Group., Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A.

Lancet Neurol. 2007 Feb;6(2):115-24.

PMID:
17239798
18.

Prognostic factors of activity limitation and discharge destination after stroke rehabilitation.

Massucci M, Perdon L, Agosti M, Celani MG, Righetti E, Recupero E, Todeschini E, Franceschini M; Italian Cooperative Research (ICR2)..

Am J Phys Med Rehabil. 2006 Dec;85(12):963-70.

PMID:
17033592
19.

Development of clinical guidelines: methodological and practical issues.

Ricci S, Celani MG, Righetti E.

Neurol Sci. 2006 Jun;27 Suppl 3:S228-30. Review.

PMID:
16752054
20.

Piracetam for acute ischaemic stroke.

Ricci S, Celani MG, Cantisani AT, Righetti E.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000419. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD000419.

PMID:
16625535
Items per page

Supplemental Content

Loading ...
Support Center